Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02909699 · ClinicalTrials.gov registry record

Cardiovascular Health of Older Adults and Resveratrol (CORE)

A clinical trial, sponsored by University of Florida.

Completed
Registry status
27
Enrollment target

NCT02909699 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 27 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02909699 has completed, sponsored by University of Florida.

COMPLETED
Registry status
27 participants
Enrollment target

Study Summary

This study will investigate how resveratrol (phenol present in red grapes, wine and peanuts) can improve heart muscle function and ability of arteries to dilate in response to an increase in blood flow in adults 65 years of age and older. Additionally, investigators will look at how resveratrol can improve functioning of cells (cellular house-keeping) which can be related to cardiovascular function.

Interventions

  • OTHER Observation

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2016-11
Est. Completion 2018-03-31

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT02909699

The ClinicalTrials.gov registry entry for NCT02909699 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Observation is the first listed.

NCT02909699 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02909699 about?

NCT02909699 is a clinical study titled "Cardiovascular Health of Older Adults and Resveratrol (CORE)". This study will investigate how resveratrol (phenol present in red grapes, wine and peanuts) can improve heart muscle function and ability of arteries to dilate in response to an increase in blood flow in adults 65 years of age and older. Additionally, investigators will look at how resveratrol can ...

What is the current status of trial NCT02909699?

This trial is currently completed. The enrollment target is 27 participants. The study started on 2016-11. Estimated completion is 2018-03-31.

What interventions are being tested in trial NCT02909699?

The interventions under investigation include: Observation (OTHER).

Who is sponsoring clinical trial NCT02909699?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.